(P-105) Aztreonam-Avibactam Compared with Adjunctive Colistin Combined with Meropenem for the Treatment of Serious Gram-Negative Bacterial Infections: Subgroup Analysis of the Phase 3 REVISIT Study

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

JY

Jinyi Yuan, MD

Institute of Antibiotics, Huashan Hospital, Fudan University
Shanghai, Shanghai, China
Yehuda Carmeli, MD

Professor of Medicine, Head of the Israeli National Center for Antibiotic Resistance, Chief of the Division of Epidemiology
Israel Ministry of Health
Tel Aviv, Tel Aviv, Israel
JC

Jose-Miguel Cisneros, MD, PhD

Virgen del Rocío University Hospital-IBiS
Seville, Andalucia, Spain
GD

Georgios L. Daikos, PhD

Professor
laiko General Hospital
Athens, Attiki, Greece
Mical Paul, MD

Director, Infectious Diseases Institute
Rambam Health Care Campus
Haifa, HaZafon, Israel
YZ

Yongjie Zhao, MD

Tianjin Union Medical Center
Tianjin, Hebei, China
JX

Jinfu Xu, MD

Shanghai Pulmonary Hospital
Shanghai, Shanghai, China
YM

Ying Ma, MD

Pfizer
Shanghai, Shanghai, China
WX

Wenjuan Xu, MD

Pfizer
Shanghai, Shanghai, China
MW

Michele Wible, MS

Pfizer WW Research & Development
Collegeville, Pennsylvania, United States
JL

Joanne Leaney, PhD

Pfizer WW Research & Development
Sandwich, England, United Kingdom
MW

Minggui Wang, MD

Professor
Institute of Antibiotics, Huashan Hospital, Fudan University
Shanghai, Shanghai, China (People's Republic)